Clinical Trial Update: Drug Interaction Study of Saxagliptin in Combination With Dapagliflozin in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 drug-interaction study assessing saxagliptin in combination with dapagliflozin in healthy participants; results completed and posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Saxagliptin (Onglyza) (saxagliptin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2013-12-23